Cas No.: | 1247825-37-1 |
Chemical Name: | 2-Thiophenecarboxamide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(methylsulfonyl)phenyl]- |
Synonyms: | 2-Thiophenecarboxamide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(methylsulfonyl)phenyl]- |
SMILES: | ClC1=CN=CC(Cl)=C1SC2=C(C#N)C=C(C(NC3=CC=C(S(C)(=O)=O)C=C3)=O)S2 |
Formula: | C18H11Cl2N3O3S3 |
M.Wt: | 484.4 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | USP7/USP47 inhibitor is a potent and dual inhibitor of USP7/USP47 with IC50s of 0.42 uM(USP7) and 1.0 uM(USP47). IC50 value: 0.42/1.0 uM (USP7/47) Target: USP7/USP47 USP7/USP47 inhibitor(compound 14) is a selective USP7 (EC50= 0.42 μM)/USP47 (EC50= 1.0 μM) inhibitor but does not inhibit caspase 3, calpain 1, 20S proteasome, and a panel of representative USPs (USP2, USP5, USP8, USP21, and USP28; EC50 > 31.6 μM Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47. compound 14 exhibits enhanced potency against HCT-116 cells. treatment of cells with compound 14 resulted in an increase in p53 and an appreciable induction of p21 protein over the DMSO control. Thus, compound 14 penetrated the cells and modulated p53 and p21 as expected For a USP7 inhibitor .For the detailed information of USP7-USP47 inhibitor, the solubility of USP7-USP47 inhibitor in water, the solubility of USP7-USP47 inhibitor in DMSO, the solubility of USP7-USP47 inhibitor in PBS buffer, the animal experiment (test) of USP7-USP47 inhibitor, the cell expriment (test) of USP7-USP47 inhibitor, the in vivo, in vitro and clinical trial test of USP7-USP47 inhibitor, the EC50, IC50,and Affinity of USP7-USP47 inhibitor, Please contact DC Chemicals. |